Pheast Therapeutics reported raising $75.3 Million in an initial SEC Form D filing, from an offering of $75.3 Million
Round Type
Venture
Palo AltoBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Pheast Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- MeliBio raised $5.7M (Seed) on March 17, 2022.
- U.S. Renal Care raised $2.8M (Seed) on March 17, 2022.
- Triumvira Immunologics Inc. raised an undisclosed amount (Series A) on March 17, 2022.
- Volta Labs raised $20M (Series A) on March 17, 2022.
- Canopy raised $13M (Funding Round) on March 17, 2022.
- GENENEWS LTD raised $1.5M (Seed) on March 17, 2022.
Who to call at Pheast Therapeutics, and when
A new round usually means Pheast Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pheast Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pheast Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pheast Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pheast Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Pheast Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.